Melanoma
9 videos · last 6 months shuffled daily, then older videos newest first
▶
1:09 Reacting to the FDA Advisory Committee Verdict on RP1 in Melanoma
Vincent Ma gives his impressions of the FDA advisory committee meeting on RP1 in melanoma, where the vote favoured the oncolytic therapy 10 to 3.
▶
8:03 Personalised Melanoma Vaccine Trial Results Explained
BBC News explains trial results showing a personalised vaccine given with an immunotherapy drug stopped melanoma returning, how personalised vaccines are made, their production challenges and when patients could get it.
▶
53:52 The TIME Trial: Does Immunotherapy Timing Matter in Melanoma?
Dr. Omid Hamid of The Angeles Clinic, Dr. Ryan Sullivan of Massachusetts General Hospital and colleagues explain the TIME Trial, testing whether earlier-in-the-day immunotherapy affects outcomes in advanced melanoma, for the Melanoma Research Alliance.
▶
9:00 Background and Goals of a New Trial of Sulforaphane for Melanoma Prevention (EA6232)
An AIM at Melanoma presentation on EA6232, a newly launched Phase 2 trial testing broccoli-sprout-derived sulforaphane to prevent melanoma in high-risk people with atypical moles.
▶
25:28 Personalised Melanoma Vaccine and US mRNA Research Funding
BBC News speaks to Tom Whipple, host of BBC Inside Science, about a personalised mRNA vaccine that stopped melanoma returning in a trial, and how US cuts to mRNA vaccine research funding could affect health outcomes.
▶
1:06:02 TIL Therapy for Melanoma: A Patient Perspective and What’s New in Research
The Melanoma Research Alliance on tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma — a patient's perspective, and what is new in the research.
▶
20:33 Melanoma Clinical Trials at University of Colorado
The University of Colorado Cancer Center and the Cancer Clinical Trials Office perform clinical trials for melanoma and this video provides a general look at the capabilities of CU and kinds of basic questions a participant might as about the trials.
▶
40:36 Compassionate Use in Melanoma & the Emerging RP1 Therapy
The Melanoma Research Alliance on compassionate use in melanoma — how patients who have exhausted approved options and do not qualify for a trial may request access to therapies still under review — and the emerging RP1 therapy.
▶
4:37 Personalized mRNA Cancer Vaccine From Moderna
Moderna CEO discusses Phase 2 clinical trials by Moderna and Merck of a mRNA cancer vaccine showing "significant improvement" for melanoma when the mRNA vaccine used in combination with Keytruda.